Biosimilar Newsletter Archive
-
04.07.22 -- Biosimilar Interchangeability: Regulatory & Practical Considerations
4/7/2022
04/07/22 Biosimilar Development Newsletter
-
04.06.22 -- Emerging Bio Executives Tackle Regulatory, GMP And Talent Challenges
4/6/2022
04/06/22 Biosimilar Development Newsletter
-
04.05.22 -- Listen Now: CAR T-cells for Ovarian Cancer, Cell and Gene Solid Tumor Therapies, and more.
4/5/2022
04/05/22 Biosimilar Development Newsletter
-
04.04.22 -- Process Intensification Strategies To Maximize Productivity And Efficiency
4/4/2022
04/04/22 Biosimilar Development Newsletter
-
03.31.22 -- OncyoBio Initiates Clinical Trial For First Biosimilar Product
3/31/2022
03/31/22 Biosimilar Development Newsletter
-
03.30.22 -- Process Intensification Strategies To Maximize Productivity And Efficiency
3/30/2022
03/30/22 Biosimilar Development Newsletter
-
03.24.22 -- Data Management: 5 Best Practices For Emerging Biotechs For Emerging
3/24/2022
03/24/22 Biosimilar Development Newsletter
-
03.18.22 -- Enabling The Delivery Of Complex Biologics
3/18/2022
03/18/22 Biosimilar Development Newsletter
-
03.17.22 -- FDA Offers Funding For Biosimilar Regulatory Science Pilot
3/17/2022
03/17/22 Biosimilar Development Newsletter
-
03.10.22 -- Purify And Analyze His-Tagged Proteins
3/10/2022
03/10/22 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more